从胰腺和局部排水淋巴结组织的空间转录学揭示了在人类1型糖尿病中淋巴毒素-β的特征
Miguel A Medina-Serpas1,2, Maigan Brusko1,2, Gregory J Golden3,4
1Diabetes Institute, University of Florida, Gainesville, FL 32610, USA.
bioRxiv : the preprint server for biology
|June 6, 2025
概括
这项研究使用空间转录学来揭示1型糖尿病 (T1D) 发育期间胰腺和胰腺淋巴结的明显炎症模式. 这些发现突出了关键的炎症基因和细胞类型,有助于未来的T1D治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 基因组学就是基因组学.
背景情况:
- 1型糖尿病 (T1D) 是一种自身免疫性疾病,其特征是胰腺β细胞的破坏.
- 了解T1D发病的早期炎症过程对于开发有效的干预措施至关重要.
- 现有的研究往往缺乏空间分辨率,以确定组织内的炎症部位.
研究的目的:
- 在T1D的自然史期间,研究胰腺和胰腺淋巴结 (pLN) 组织中的空间炎症格局.
- 通过空间转录学 (ST) 来识别与T1D发展相关的特定细胞和分子特征.
- 将ST数据与单细胞RNA测序集成在一起,以全面了解T1D病原性.
主要方法:
- 空间转录学 (ST) 应用于来自T1D频谱的个体的胰腺和pLN样本.
- 将ST数据与公开可用的单细胞RNA测序数据集集集成.
- 在组织和细胞水平上对转录性变化的分析.
主要成果:
- 在T1D胰腺中观察到与炎症相关的转录的全球上调,包括再生小岛衍生 (REG) 基因,补充因子3 (C3),SOD2和OLFM4.
- 识别可能驱动这些胰腺炎症特征的细胞候选者.
- 在T1D pLN中,淋巴毒素-β (LTB) 和卵泡树突细胞 (FDC) 相关的转录 (FDCSP,CLU,FCER2) 的空间限制上调.
结论:
- 在T1D发病过程中,胰腺和区域pLN存在明显的炎症特征.
- 这些空间解析的发现为T1D进展提供了新的见解.
- 确定了分子和细胞点,可以为针对性T1D治疗的开发提供信息.
相关概念视频
Type I Diabetes I: Introduction
64
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
64
Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36


